“What if the CIA did Woke?”: Reviewing Netflix’s “The Business of Drugs”

Editor’s Note: Today’s post comes from contributing editor Brooks Hudson, a PhD student in history at Southern Illinois University. He reviews the new Netflix series “The Business of Drugs.”

Screenshot 2020-08-12 at 8.33.12 PM

Netflix’s new series The Business of Drugs investigates six psychoactive substances—cocaine, synthetics, heroin, cannabis, methamphetamine, and opioids—tracing them to global hot spots—from the remote villages of Colombia, to the ailing slums on Kenya’s periphery, to Myanmar’s contested regions, where ethnic strife is fueled by the factory-level output of methamphetamine (or “yaba”). Other installments are less global, and narrowly tailored for American consumers, catering to hot-button domestic issues: the causes and consequences of the opioid epidemic, MDMA’s potential as a breakthrough therapeutic, and the overregulation of California’s legal cannabis markets. 

Read more